Clinical Trial Update: Pharmacokinetic Study Of EPZICOM Tablet [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic study of EPZICOM (abacavir/lamivudine) in HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EPZICOM Tablet (abacavir/lamivudine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV Infection | Phase 4 | Status: COMPLETED